- Home
- MPC vs ZTS Comparison
MPC vs ZTS Comparison
Compare MPC & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPC
- ZTS
- Stock Information
- Founded
- MPC 1887
- ZTS 1952
- Country
- MPC United States
- ZTS United States
- Employees
- MPC 18300
- ZTS N/A
- Industry
- MPC Integrated oil Companies
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- MPC Energy
- ZTS Health Care
- Exchange
- MPC Nasdaq
- ZTS Nasdaq
- Market Cap
- MPC 59.3B
- ZTS 66.2B
- IPO Year
- MPC 2011
- ZTS 2013
- Fundamental
- Price
- MPC $181.55
- ZTS $127.41
- Analyst Decision
- MPC Buy
- ZTS Buy
- Analyst Count
- MPC 13
- ZTS 7
- Target Price
- MPC $199.15
- ZTS $194.29
- AVG Volume (30 Days)
- MPC 1.6M
- ZTS 2.8M
- Earning Date
- MPC 11-04-2025
- ZTS 11-04-2025
- Dividend Yield
- MPC 1.86%
- ZTS 1.39%
- EPS Growth
- MPC N/A
- ZTS 14.10
- EPS
- MPC 6.69
- ZTS 5.82
- Revenue
- MPC $133,862,000,000.00
- ZTS $9,385,000,000.00
- Revenue This Year
- MPC N/A
- ZTS $3.85
- Revenue Next Year
- MPC N/A
- ZTS $5.89
- P/E Ratio
- MPC $29.25
- ZTS $24.81
- Revenue Growth
- MPC N/A
- ZTS 5.27
- 52 Week Low
- MPC $115.10
- ZTS $139.34
- 52 Week High
- MPC $201.61
- ZTS $181.85
- Technical
- Relative Strength Index (RSI)
- MPC 41.70
- ZTS 20.88
- Support Level
- MPC $193.33
- ZTS $145.18
- Resistance Level
- MPC $196.53
- ZTS $144.83
- Average True Range (ATR)
- MPC 4.92
- ZTS 2.64
- MACD
- MPC -0.62
- ZTS -1.01
- Stochastic Oscillator
- MPC 25.54
- ZTS 20.57
About MPC Marathon Petroleum Corporation
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 3.0 million barrels per day. Its Dickinson, North Dakota, facility produces 184 million gallons a year of renewable diesel. Its Martinez, California, facility has the ability to produce 730 million gallons a year of renewable diesel. The firm also owns and operates midstream assets primarily through its listed master limited partnership, MPLX.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.